Pegylated interferon

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Pegylated interferon (PEG-IFN) is a class of medication that includes three different drugs as of 2012:[1]

In these formulation, PEG is added to make interferon last longer in the body.[3] They are used to treat both hepatitis B,[4] hepatitis C[1] and multiple sclerosis.[2]

References[edit]

  1. ^ a b editor, Emilio Jirillo, (2008). Hepatitis C virus disease : immunobiology and clinical applications ([Online-Ausg.] ed.). New York: Springer. p. 237. ISBN 978-0-387-71375-5. 
  2. ^ a b Kieseier BC, Calabresi PA. (2012). "PEGylation of Interferon-β-1a: A Promising Strategy in Multiple Sclerosis". CNS Drugs 26 (3): 205–14. doi:10.2165/11596970-000000000-00000. PMID 22201341. 
  3. ^ http://www.medscape.com/viewarticle/407963_5 Hepatology Focus: Update on Hepatitis C Treatment: Pegylated Interferon
  4. ^ Clinical Hepatology. [S.l.]: Springer Berlin Heidelberg. 2010. p. 765. ISBN 978-3-642-04509-7.